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Abstract 
Following the outbreak of COVID-19 since December 2019 many reports have 
been published to conclude different presentations of this new infection. This 
report contains a summary of a young patient with a history of methadone 
intake, which experienced a cardiopulmonary arrest while he was preparing to 
take a lung Computerized Tomography (CT) scan in an outpatient setting. After 
a successful Cardio-Pulmonary Recovery in the CT scan room he was admitted 
in Intensive Care Unit. He had a prolonged QTc interval in Electrocardiograph 
and bilateral pulmonary involvement in Chest X-Ray. 
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Introduction 
Coronavirus is a family of viruses that cause 
illness in a widely variable severity; from the common 
cold in some patients to a severe pneumonia as in 
SARS2 and Middle East Respiratory Syndrome 
(MERS) (1). Since December 2019, an outbreak was 
reported in China which was caused by a novel 
coronavirus, later named COVID-19. WHO declared a 
pandemic by 11 March 2020 (2). After virus 
documentation and separation, the pathogen intended 
for this pneumonia was initially named 2019 novel 
coronavirus (2019-nCoV) (3), nevertheless has 
consequently been legitimately called severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) 
via WHO (4). The problem has many unique and even 
unknown features that human being has never been 
faced with (5). COVID-19 mortality rate (MR) and 
case fatality rate (CFR) depend on some factors; such 
as gender, age and underlying disease, etc. According 
to recent studies, COVID19 associated mortality is 
significantly higher in males compared to females (6). 
Here, we report the case of a young man who was 
awake and conscious but needed CPR a few minutes 
later; basic and advanced CPR were performed while 
the patient was on the floor of the CT unit.  
Case Report 
The current case report was approved by the 
IRB ethics committeee, Research Deputy, SBMU, 
Tehran, Iran. A 37-year-old man with no significant 
past medical history with Dry cough, fatigue, myalgia 
and without fever and coryza, was referred to a medical 
center, while being recommended to stay home and 
rest. The patient had no past medical or smoking 
history, but the history of methadone abuse according 
to his companion; while denying any recent methadone 
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intake. 
Due to his symptoms, a chest Computerized 
Tomographic (CT) scanning was ordered. When 
entering the CT unit in the radiology department, he 
suddenly fell down on the ground, mandating prompt 
call for Cardio-Pulmonary Resuscitation (CPR) which 
was started immediately with chest compression, while 
he had fallen on the ground, had no breathing, no distal 
or carotid pulses and also was unconscious and pale. 
Using direct laryngoscopy, he was intubated by No. 8 
cuffed endotracheal tube. Rescue breaths were given 
using bag mask ventilation with a frequency of 
10/minute. Then, the first doses of epinephrine were 
injected into the endotracheal tube; while chest 
compression was continued. Intravenous access was 
taken meanwhile without any pause in chest 
compression; every 3-5 min 1 mg of intravenous 
epinephrine was repeated. The latter steps were done 
while the patient was on the ground; since there was no 
opportunity to move him off the ground and the health 
care personnel had their standard personal protection 
equipments.  
After 25 minutes of CPR, weak central pulses 
were detected, with a sinus bradycardia rhythm. When 
the patient’s condition became a bit more stable, he 
was moved to the intensive care unit (ICU); where, 
clinical signs including fever (38 degrees centigrade), 
tachycardia and consciousness were still persistent. In 
electrocardiogram, prolonged QT interval had been 
found (Figure 1).  
Both lungs in auscultation had diffused rales; 
compatible with CT scan imaging; revealing moderate 
global cardiomegaly, associated with mild to moderate 
pleural effusion, more prominent on the right side as 
well as mild diffused ground glass opacities 
prominently in the Right Lower Lobe (RLL). In 
addition, patchy air space and ground glass opacities 
were found throughout both lung fields, most 
prominently in the central regions of RLL (Figure 2). 
 
Discussion 
Sudden cardiopulmonary arrest of this patient, 
who was managed in situations much different from 
standard care could be linked to COVID-19 induced 
myocardial damage. Studies have demonstrated that 
the Middle East respiratory syndrome-related 
coronavirus (MERS-CoV) can be the etiology of acute 
myocarditis and heart failure (7). SARS-CoV-2 and 
MERS-CoV have many pathologic and clinical 
features in common, and the myocardial injury 
 





Figure 2. CT scan mild diffused ground glass opacities more prominently in RLL. Patchy air space and ground glass opacities 
both lung fields. 
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triggered by both of these infections would 
undoubtedly surge the strain and intricacy of patient 
management. Myocardial damage as a concomitant 
finding in SARS-CoV-2 infection has been reported in 
5 of the first 41 patients identified with COVID-19  in 
Wuhan, China; which was associated with a significant 
rise in cardiac troponin I (hs-cTnI) levels (>28 pg./ml) 
(7). 
Arrhythmias have been reported as COVID-19 
cardiovascular manifestations (8, 9); although a 
specific arrhythmia has not been described as the 
hallmark of COVID-19 yet (8). Prolonged QTc 
interval-induced arrhythmia is a potential etiology for 
cardiopulmonary arrest in patients like this case. 
However, it is a challenge in differential diagnosis of 
this patient whether or not methadone intake induced 
prolonged QT interval; however, in COVID-19 
patients, methadone-induced prolonged QTc interval 
should be placed somewhere in the differential 
diagnosis list, especially in those with a suspicious 
history (10). In addition animal studies have 
demonstrated COVID-19 might prolong QTc interval 
per se (11).  
Conclusion 
According to this report, sudden 
cardiopulmonary arrest can be one of the consequences 
of COVID-19, especially in patients with sudden 
cardiac arrest. This presentation, though rare, is an 
important issue since it could potentially lead to sudden 
unexplained death. Drugs like methadone, which are 
known to prolong QTc interval, may make patients 
more susceptible to cardiac complications. 
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